1. Home /
  2. Life Sciences

Life Sciences

After a Significant Correction, Beam Therapeutics Looks Interesting Again

Here's what aggressive traders could do now.

Novocure Breaks a Major Support Zone: What Now?

Here's what smashing what was a zone of support means for the stock.

Why Are CRISPR Therapeutics Charts Saying 'Buy'?

Here's where traders could go long.

Intuitive Surgical's Charts Are Flashing Positive Signs Ahead of Earnings

The maker of robotic products for minimally invasive surgery looks like a long play based on its technical signals.

Regeneron Set to Reach New Heights: $1,000 in Sight?

Here's how traders can play it.

Johnson & Johnson's Rally Does Not Move the Needle

It will take more than the company's potential talc litigation settlement to reverse the stock's downward path the past 12 months.

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

BSX has rallied the past nine months.

Novavax's Charts Are in Critical Condition

Trying to catch this drug developer's stock appears risky.

It's Time to Reevaluate Moderna's Charts

Here's what I think we'll see up ahead.

Are Danaher Shares Poised for a Rally?

Keep this stock on your watch list.